636 related articles for article (PubMed ID: 29193765)
1. Group for Research and Assessment of Psoriasis and Psoriatic Arthritis/Outcome Measures in Rheumatology Consensus-Based Recommendations and Research Agenda for Use of Composite Measures and Treatment Targets in Psoriatic Arthritis.
Coates LC; FitzGerald O; Merola JF; Smolen J; van Mens LJJ; Bertheussen H; Boehncke WH; Callis Duffin K; Campbell W; de Wit M; Gladman D; Gottlieb A; James J; Kavanaugh A; Kristensen LE; Kvien TK; Luger T; McHugh N; Mease P; Nash P; Ogdie A; Rosen CF; Strand V; Tillett W; Veale DJ; Helliwell PS
Arthritis Rheumatol; 2018 Mar; 70(3):345-355. PubMed ID: 29193765
[TBL] [Abstract][Full Text] [Related]
2. Initiating Evaluation of Composite Outcome Measures for Psoriatic Arthritis: 2022 Updates From the GRAPPA-OMERACT Working Group.
Leung YY; Tillett W; de Wit M; Orbai AM; Coates LC; FitzGerald O; Helliwell PS; Strand V; Mease PJ; Goel N; Christensen R; Merola JF; Lindsay CA; Ogdie A; Gossec L; Gladman DD
J Rheumatol; 2023 Nov; 50(Suppl 2):53-57. PubMed ID: 37419621
[TBL] [Abstract][Full Text] [Related]
3. Development of a disease activity and responder index for psoriatic arthritis--report of the Psoriatic Arthritis Module at OMERACT 11.
Coates LC; FitzGerald O; Mease PJ; Gladman DD; Strand V; Goel N; Campbell I; Krueger G; McHugh NJ; Helliwell PS
J Rheumatol; 2014 Apr; 41(4):782-91. PubMed ID: 24488420
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of the 2019 GRAPPA Workshop on Continuous Composite Indices for the Assessment of Psoriatic Arthritis and Membership-recommended Next Steps.
Tillett W; McHugh N; Orbai AM; Ogdie A; Leung YY; Coates LC; Mease PJ; Gladman DD; Brooke M; Packham J; O'Sullivan D; FitzGerald O; Helliwell PS
J Rheumatol Suppl; 2020 Jun; 96():11-18. PubMed ID: 32482762
[TBL] [Abstract][Full Text] [Related]
5. Measuring psoriatic arthritis symptoms: A core domain in psoriasis clinical trials.
Perez-Chada LM; Gottlieb AB; Cohen J; Mease P; Duffin KC; Garg A; Latella J; Armstrong AW; Ogdie A; Merola JF
J Am Acad Dermatol; 2020 Jan; 82(1):54-61. PubMed ID: 31163240
[TBL] [Abstract][Full Text] [Related]
6. Updating the Psoriatic Arthritis (PsA) Core Domain Set: A Report from the PsA Workshop at OMERACT 2016.
Orbai AM; de Wit M; Mease PJ; Callis Duffin K; Elmamoun M; Tillett W; Campbell W; FitzGerald O; Gladman DD; Goel N; Gossec L; Hoejgaard P; Leung YY; Lindsay C; Strand V; van der Heijde DM; Shea B; Christensen R; Coates L; Eder L; McHugh N; Kalyoncu U; Steinkoenig I; Ogdie A
J Rheumatol; 2017 Oct; 44(10):1522-1528. PubMed ID: 28148697
[TBL] [Abstract][Full Text] [Related]
7. The GRAPPA-OMERACT Psoriatic Arthritis Working Group at the 2018 Annual Meeting: Report and Plan for Completing the Core Outcome Measurement Set.
Leung YY; Orbai AM; Ogdie A; Coates LC; de Wit M; Callis Duffin K; Eder L; Gladman DD; Goel N; Mease PJ; Strand V; FitzGerald O; Tillett W
J Rheumatol Suppl; 2019 Jun; 95():33-37. PubMed ID: 31154402
[TBL] [Abstract][Full Text] [Related]
8. Content and Face Validity and Feasibility of 5 Candidate Instruments for Psoriatic Arthritis Randomized Controlled Trials: The PsA OMERACT Core Set Workshop at the GRAPPA 2017 Annual Meeting.
Holland R; Tillett W; Ogdie A; Leung YY; Gladman DD; Callis Duffin K; Coates LC; Mease PJ; Eder L; Strand V; Elmamoun M; Højgaard P; Chau J; de Wit M; Goel N; Lindsay CA; FitzGerald O; Shea B; Beaton D; Orbai AM
J Rheumatol Suppl; 2018 Jun; 94():17-25. PubMed ID: 29858348
[TBL] [Abstract][Full Text] [Related]
9. PsAID12 Provisionally Endorsed at OMERACT 2018 as Core Outcome Measure to Assess Psoriatic Arthritis-specific Health-related Quality of Life in Clinical Trials.
Orbai AM; Holland R; Leung YY; Tillett W; Goel N; Christensen R; McHugh N; Gossec L; de Wit M; Højgaard P; Coates LC; Mease PJ; Birt J; Fallon L; FitzGerald O; Ogdie A; Shea B; Strand V; Duffin KC; Tugwell P; Beaton D; Gladman DD
J Rheumatol; 2019 Aug; 46(8):990-995. PubMed ID: 30554154
[TBL] [Abstract][Full Text] [Related]
10. Prologue: 2019 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA).
Callis Duffin K; Gladman DD; Goel N; Gottlieb AB
J Rheumatol Suppl; 2020 Jun; 96():1-3. PubMed ID: 32482760
[TBL] [Abstract][Full Text] [Related]
11. International patient and physician consensus on a psoriatic arthritis core outcome set for clinical trials.
Orbai AM; de Wit M; Mease P; Shea JA; Gossec L; Leung YY; Tillett W; Elmamoun M; Callis Duffin K; Campbell W; Christensen R; Coates L; Dures E; Eder L; FitzGerald O; Gladman D; Goel N; Grieb SD; Hewlett S; Hoejgaard P; Kalyoncu U; Lindsay C; McHugh N; Shea B; Steinkoenig I; Strand V; Ogdie A
Ann Rheum Dis; 2017 Apr; 76(4):673-680. PubMed ID: 27613807
[TBL] [Abstract][Full Text] [Related]
12. Composite Measures for Clinical Trials in Psoriatic Arthritis: Testing Pain and Fatigue Modifications in a UK Multicenter Study.
Tillett W; FitzGerald O; Coates LC; Packham J; Jadon DR; Massarotti M; Brook M; Lane S; Creamer P; Antony A; Korendowych E; Rambojun A; McHugh NJ; Helliwell PS;
J Rheumatol Suppl; 2021 Jun; 97():39-44. PubMed ID: 34074665
[TBL] [Abstract][Full Text] [Related]
13. Enhanced Patient Involvement and the Need to Revise the Core Set - Report from the Psoriatic Arthritis Working Group at OMERACT 2014.
Tillett W; Eder L; Goel N; De Wit M; Gladman DD; FitzGerald O; Campbell W; Helliwell PS; Gossec L; Orbai AM; Ogdie A; Strand V; McHugh NJ; Mease PJ
J Rheumatol; 2015 Nov; 42(11):2198-203. PubMed ID: 25934828
[TBL] [Abstract][Full Text] [Related]
14. Prologue: 2013 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA).
Boehncke WH; Gladman DD
J Rheumatol; 2014 Jun; 41(6):1194-6. PubMed ID: 24882850
[TBL] [Abstract][Full Text] [Related]
15. Prologue: 2016 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA).
Helliwell PS; Gladman DD; Gottlieb AB
J Rheumatol; 2017 May; 44(5):658-660. PubMed ID: 28461520
[TBL] [Abstract][Full Text] [Related]
16. Prologue: 2017 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA).
Helliwell PS; Gladman DD; Gottlieb AB
J Rheumatol Suppl; 2018 Jun; 94():1-3. PubMed ID: 29858345
[TBL] [Abstract][Full Text] [Related]
17. Report of the GRAPPA-OMERACT Psoriatic Arthritis Working Group from the GRAPPA 2015 Annual Meeting.
Orbai AM; Mease PJ; de Wit M; Kalyoncu U; Campbell W; Tillett W; Eder L; Elmamoun M; FitzGerald O; Gladman DD; Goel N; Gossec L; Lindsay CA; Steinkoenig I; Helliwell PS; McHugh NJ; Strand V; Ogdie A
J Rheumatol; 2016 May; 43(5):965-9. PubMed ID: 27134271
[TBL] [Abstract][Full Text] [Related]
18. Prologue: 2020 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA).
Duffin KC; Gottlieb AB; O'Sullivan D; Gladman DD; McFarland LV
J Rheumatol Suppl; 2021 Jun; 97():1-3. PubMed ID: 34074657
[TBL] [Abstract][Full Text] [Related]
19. Prologue: 2018 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA).
Callis Duffin K; Gladman DD; Gottlieb AB; Goel N
J Rheumatol Suppl; 2019 Jun; 95():1-3. PubMed ID: 31154397
[TBL] [Abstract][Full Text] [Related]
20. A systematic review of measurement properties of patient reported outcome measures in psoriatic arthritis: A GRAPPA-OMERACT initiative.
Højgaard P; Klokker L; Orbai AM; Holmsted K; Bartels EM; Leung YY; Goel N; de Wit M; Gladman DD; Mease P; Dreyer L; Kristensen LE; FitzGerald O; Tillett W; Gossec L; Helliwell P; Strand V; Ogdie A; Terwee CB; Christensen R
Semin Arthritis Rheum; 2018 Apr; 47(5):654-665. PubMed ID: 29037523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
